3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
7
Hematologic Neoplasms
4
Waldenstrom Macroglobulinemia
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, B-Cell
2
Vascular Diseases
1
Recurrence
1
Paraproteinemias
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasms
1
Mature B-cell Neoplasms
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Leukemia, Lymphoid
1
Leukemia
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hemostatic Disorders
1
Hemorrhagic Disorders
1
Dendritic Cell Sarcoma, Interdigitating
1
Cardiovascular Diseases
1
Blood Protein Disorders
1
Interventions
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mature B-cell Neoplasms
×
ARQ531
×
Clear all
NCT05673460
2026-05-13
MK-1026-002
Merck Sharp & Dohme LLC
Phase 1
Completed
7 enrolled
15 charts